Use of vancomycin in high-flux hemodialysis: experience with 130 courses of therapy

Kidney International
R H Barth, N DeVincenzo

Abstract

Vancomycin is often administered to hemodialysis patients at long dosage intervals because its removal by hemodialysis is considered to be negligible. We and others, however, have demonstrated significant removal of vancomycin by high-flux hemodialysis. This report describes our experience with 89 courses of vancomycin using a revised regimen with a loading dose followed by 500 mg doses after each dialysis treatment, and compares results with 41 courses using single weekly dosing. All patients were dialyzed with high-flux membranes using volumetric ultrafiltration and bicarbonate dialysate. Serum vancomycin levels were obtained two hours after completion of infusion (peak) and immediately prior to dialysis (trough) and were measured by Abbot TDx fluorescence polarization immunoassay. Duration of multiple-dose therapy was 11 +/- 8 days, with mean total dose 3.6 +/- 1.8 g. Initial doses of 20 mg/kg rapidly and reliably established therapeutic pre-dialysis serum levels (10 to 25 micrograms/ml). In patients treated with multiple dosing 431 pre-dialysis levels were obtained. The mean level was 15.9 +/- 5.7 micrograms/ml; 55 levels (13%) were less than 10 micrograms/ml and 22 (5%) were above 25 micrograms/ml. In patients treated once...Continue Reading

References

Jun 1, 1978·Annals of Internal Medicine·F V Cook, W E Farrar
Nov 1, 1979·Archives of Internal Medicine·K A NsouliM Shocair
Jan 1, 1977·Transactions - American Society for Artificial Internal Organs·W F KeaneL Raij
Oct 1, 1992·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·C A DeSoiJ G Umans
Jul 1, 1992·Antimicrobial Agents and Chemotherapy·J M QualeR H Barth
Jun 1, 1992·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·K T JensenV F Thomsen
Apr 1, 1992·The Journal of Antimicrobial Chemotherapy·B H Ackerman, A M Vannier
Jan 1, 1991·The Journal of Antimicrobial Chemotherapy·F BiavascoP E Varaldo
Jun 1, 1991·Antimicrobial Agents and Chemotherapy·E M BaileyG W Kaatz
Apr 1, 1991·The Journal of Antimicrobial Chemotherapy·A Kropec, F D Daschner
May 1, 1990·The Journal of Infectious Diseases·R N Greenberg, C A Benes
Jun 1, 1990·Antimicrobial Agents and Chemotherapy·P M Small, H F Chambers
Mar 1, 1987·Antimicrobial Agents and Chemotherapy·D P HealyT J Comstock
Jun 1, 1987·Antimicrobial Agents and Chemotherapy·R C Evans, C J Holmes
Apr 9, 1987·The New England Journal of Medicine·R S SchwalbeP H Gilligan
Dec 1, 1984·The Journal of Antimicrobial Chemotherapy·Robert C Moellering
Dec 1, 1984·The Journal of Antimicrobial Chemotherapy·C Watanakunakorn
Jan 1, 1984·Antimicrobial Agents and Chemotherapy·K J Wilson, J T Mader
Apr 1, 1984·Antimicrobial Agents and Chemotherapy·G R MatzkeW F Keane
May 1, 1984·Antimicrobial Agents and Chemotherapy·R D BlevinsG R Matzke
Sep 1, 1982·Antimicrobial Agents and Chemotherapy·John C RotschaferL D Solem
Nov 1, 1981·Reviews of Infectious Diseases·Robert C MoelleringD J Greenblatt
Nov 1, 1981·Reviews of Infectious Diseases·B A CunhaC H Nightingale
Nov 1, 1981·Reviews of Infectious Diseases·U B SchaadG H McCracken
Oct 1, 1995·The Journal of Infectious Diseases·D K ShayW R Jarvis
Sep 1, 1995·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·M A TouchetteB J Zarowitz
Apr 1, 1995·Clinical Pharmacokinetics·W G LeaderM Castiglia
Apr 1, 1995·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·J G MulhernM J Germain
Jan 1, 1994·International Urology and Nephrology·J AlwakeelH Abu-aisha
Apr 1, 1994·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·T G CantúP S Lietman
Apr 1, 1994·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Robert C Moellering
Jan 1, 1994·Kidney International·T A PollardB J Maroni
Jan 1, 1994·Journal of Orthopaedic Trauma·L X WebbE S Gordon

Citations

Feb 11, 2012·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·A A DurgaryanA A Galoyan
Apr 27, 2000·Annales Françaises D'anesthèsie Et De Rèanimation·M LéoneC Martin
Feb 19, 2002·Kidney International·Zipporah KrishnasamiMichael Allon
Dec 3, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·George SakoulasGeorge M Eliopoulos
Dec 19, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Martin E StryjewskiVance G Fowler
Jun 22, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Merideth BrownHans P Schlecht
Jun 22, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Stefaan J VandecasteeleAn S De Vriese
Mar 3, 2004·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Christopher V PooleMichael Allon
Jun 21, 2008·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Rosemary ZvonarVirginia Roth
Feb 23, 2011·Seminars in Dialysis·Stefaan J Vandecasteele, An S De Vriese
Jul 10, 2010·Clinical Journal of the American Society of Nephrology : CJASN·Brian S DeckerKevin M Sowinski
Jan 5, 2013·The Canadian Journal of Hospital Pharmacy·Wasim S El NekidyMichelle Dehoorne-Smith
Jun 5, 2012·Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia·Nadezda PetejovaIvana Kacirova
Jun 6, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Leonard A MermelDavid K Warren
Jul 15, 2015·Expert Review of Anti-infective Therapy·Karl Evans R HensonDonald P Levine
Apr 14, 2006·Expert Opinion on Drug Safety·Joshua G YorgasonFederico Kalinec
Jun 24, 2000·Journal of Toxicology. Clinical Toxicology·D J SchuererT E Bunchman
Feb 26, 2010·Kidney International·Stefaan J Vandecasteele, An S De Vriese
Dec 24, 2010·Kidney International·Charmaine E Lok, Michele Helene Mokrzycki
Oct 7, 2004·Journal of Vascular and Interventional Radiology : JVIR·T F Saad, Thomas M Vesely
Jun 18, 2011·The Medical Clinics of North America·Brett GilbertLawrence L Livornese
Feb 22, 2011·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Lynn N FitzgibbonsGraeme N Forrest
Nov 17, 2009·Infectious Disease Clinics of North America·Brett GilbertLawrence L Livornese
Oct 14, 2008·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·William J PetersonMichael Allon
Sep 11, 2007·Infectious Disease Clinics of North America·Scott J BergmanJanak Koirala
Jul 31, 2007·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Ivan D MayaMichael Allon
Sep 27, 2005·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Robert E ArianoSheryl A Zelenitsky
Sep 26, 2006·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Michele Helene MokrzyckiStuart O Rosenberg
Jun 30, 2009·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Michael Allon
May 26, 2010·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Maria E Taylor, Michael Allon
Aug 17, 2004·Infectious Disease Clinics of North America·Lawrence L LivorneseJerome Santoro
May 16, 2013·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Kazuaki MatsumotoToshimi Kimura
Oct 21, 2016·Renal Failure·Rebecca MaxsonJessica Starr
Oct 19, 2014·Journal of Intensive Care Medicine·Susan J Lewis, Bruce A Mueller
May 6, 2017·Clinical Pharmacology and Therapeutics·E J FilipponeJ L Farber
Apr 25, 2015·The Journal of Vascular Access·Maristela BöhlkeFranklin C Barcellos
Sep 29, 2011·ASAIO Journal : a Peer-reviewed Journal of the American Society for Artificial Internal Organs·Kostas I SombolosChristina I Fytili
Oct 23, 2015·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Page CrewBrett H Heintz
Aug 21, 2007·Clinical Journal of the American Society of Nephrology : CJASN·Michael Allon
Dec 29, 1998·Current Opinion in Nephrology and Hypertension·E O'Riordan, P J Conlon
Apr 29, 1998·Therapeutic Drug Monitoring·M AdamczykA G Costantino
Feb 20, 2002·Seminars in Dialysis·T F Saad
Feb 5, 2015·The International Journal of Artificial Organs·Marco SartoriClaudio Ronco

Related Concepts

Bacteriocidal Agents
Bacterial Infections
Dose-Response Relationship, Drug
Hemodialysis
AB-Vancomycin

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Lipidomics & Rhinovirus Infection

Lipidomics can be used to examine the lipid species involved with pathogenic conditions, such as viral associated inflammation. Discovered the latest research on Lipidomics & Rhinovirus Infection.

Glut1 Deficiency

Glut1 deficiency, an autosomal dominant, genetic metabolic disorder associated with a deficiency of GLUT1, the protein that transports glucose across the blood brain barrier, is characterized by mental and motor developmental delays and infantile seizures. Follow the latest research on Glut1 deficiency with this feed.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Alzheimer's Disease: MS4A

Variants within the membrane-spanning 4-domains subfamily A (MS4A) gene cluster have recently been implicated in Alzheimer's disease in genome-wide association studies. Here is the latest research on Alzheimer's disease and MS4A.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Laryngeal Neoplasms

Laryngeal Neoplasms occur in the Larynx and are typically associated with smoking and alcohol consumption. Discover the latest research on Laryngeal Neoplasms here.

Cell Atlas Along the Gut-Brain Axis

Profiling cells along the gut-brain axis at the single cell level will provide unique information for each cell type, a three-dimensional map of how cell types work together to form tissues, and insights into how changes in the map underlie health and disease of the GI system and its crosstalk with the brain. Disocver the latest research on single cell analysis of the gut-brain axis here.

Related Papers

American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
Robert E ArianoSheryl A Zelenitsky
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
Anand VardhanPeter McClelland
The Journal of Antimicrobial Chemotherapy
T Sandberg, B Trollfors
Kidney International
Stefaan J Vandecasteele, An S De Vriese
© 2021 Meta ULC. All rights reserved